Stocks of Kukje Pharm will continue to provide good opportunities for investors to reap impressive gains going forward given its positive business prospects in the future, said an analyst of Daewoo Securities.
The market outlook for Kukje continues to be rosy, posting an average growth of 10 percent annually, with rapidly increasing profitability, said the analyst.
Since Kukje is shifting...
Fees
- Email service daily and homepage access.
- $300 per month.
- 5 Email holders per each company.
- Anual contract base.
Copyright Yakup.com All rights reserved.
약업닷컴의 모든 컨텐츠는 저작권법의 보호를 받습니다. 무단 전재⋅복사⋅배포 등을 금합니다.